Morgan Stanley
NDRA icon

Morgan Stanley’s ENDRA Life Sciences NDRA Stock Holding History

Morgan Stanley’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9K Hold
3,546
– – ﹤0.01% 6841
2026
Q1 		$16.5K Sell
3,546
-3,400
-49% -$13.5K ﹤0.01% 6796
2025
Q4 		$31.5K Buy
+6,946
New +$39.6K ﹤0.01% 6565
2025
Q1 		– Sell
-13
Closed -$81 – 8179
2024
Q4 		$81 Sell
13
-62
-83% -$413 ﹤0.01% 7500
2024
Q3 		$526 Buy
75
+69
+1,150% +$5.35K ﹤0.01% 7296
2024
Q2 		$1K Buy
+6
New +$2.58K ﹤0.01% 7154
2024
Q1 		– Hold
0
– – – 7312
2023
Q4 		– Hold
0
– – – 7173
2023
Q3 		– Hold
0
– – – 7253
2023
Q2 		– Sell
-15
Closed -$42.2K – 7282
2023
Q1 		$58.9K Sell
15
-10
-40% -$67.9K ﹤0.01% 6217
2022
Q4 		$176K Hold
25
– – ﹤0.01% 5720
2022
Q3 		$265K Buy
25
+1
+4% +$10.3K ﹤0.01% 5587
2022
Q2 		$199K Hold
24
– – ﹤0.01% 5898
2022
Q1 		$332K Hold
24
– – ﹤0.01% 5626
2021
Q4 		$583K Buy
24
+17
+243% +$722K ﹤0.01% 5452
2021
Q3 		$402K Hold
7
– – ﹤0.01% 5628
2021
Q2 		$506K Buy
7
+1
+17% +$78.7K ﹤0.01% 5517
2021
Q1 		$573K Buy
+6
New +$449K ﹤0.01% 5077
2020
Q4 		– Hold
0
– – – 6741
2020
Q3 		– Hold
0
– – – 6246
2020
Q2 		– Hold
0
– – – 6457
2020
Q1 		– Hold
0
– – – 6474
2019
Q4 		– Hold
0
– – – 6431
2019
Q3 		– Hold
0
– – – 6482
2019
Q2 		– Hold
0
– – – 6313
2019
Q1 		– Hold
0
– – – 6401
2018
Q4 		– Hold
0
– – – 6422
2018
Q3 		– Hold
0
– – – 6447

Other funds holding NDRA

ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Morgan Stanley's NDRA Position: Q2 2026 in Review

Morgan Stanley held its ENDRA Life Sciences (NDRA) position steady in Q2 2026 at 3,546 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6841.

Morgan Stanley first reported a position in NDRA in Q1 2021 and has held it in 15 quarters since. The position peaked at $583K in Q4 2021. 10 funds tracked by Wall St. Rank hold NDRA as of Q2 2026.

  • Morgan Stanley held 3,546 shares of ENDRA Life Sciences worth $18.9K as of Q2 2026.
  • Morgan Stanley left its ENDRA Life Sciences share count unchanged in Q2 2026.
  • ENDRA Life Sciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6841 holding.
  • Morgan Stanley first reported a position in ENDRA Life Sciences in Q1 2021 and has held it in 15 quarters since.
  • Morgan Stanley's ENDRA Life Sciences position peaked at $583K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.